Insider holders · CIK 0000884731
ARIAD PHARMACEUTICALS INC · ARIA
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Harvey J M D BergerChairman & CEO | 1,732,111 | 245,251 | 1,977,362 | Jan 5, 2016 · 5:41 pm EST | Form 4 |
| Jay R LamarcheDirector | 552,205 | 6,696 | 558,901 | Feb 9, 2016 · 5:31 pm EST | Form 4/A |
| Edward M FitzgeraldExecutive VP | 320,367 | — | 320,367 | Mar 22, 2016 · 4:01 pm EDT | Form 4 |
| David L BersteinSVP, Chief IP Counsel | 262,115 | — | 262,115 | Mar 22, 2016 · 4:02 pm EDT | Form 4 |
| Frank HaluskaSVP, Clinical R&D, CMO | 158,711 | — | 158,711 | May 2, 2016 · 5:33 pm EDT | Form 4 |
| Maria E CantorSVP, Corporate Affairs | 144,667 | — | 144,667 | May 2, 2016 · 5:32 pm EDT | Form 4 |
| Athanese LavidasDirector | 131,631 | — | 131,631 | Jun 15, 2016 · 4:19 pm EDT | Form 4 |
| Wayne WilsonDirector | 125,500 | — | 125,500 | Feb 3, 2016 · 5:15 pm EST | Form 4 |
| Massimo RadaelliDirector | 105,500 | — | 105,500 | Jun 14, 2016 · 6:13 pm EDT | Form 4 |
| Martin J DuvallEVP, CCO | 105,189 | — | 105,189 | May 2, 2016 · 5:26 pm EDT | Form 4 |
| Thomas DesRosierEVP, General Counsel | 36,630 | — | 36,630 | Mar 30, 2016 · 5:04 pm EDT | Form 4 |
| Jennifer Lyn HerronExec V.P. Chief Comm'l Officer | 0 | — | 0 | Feb 16, 2017 · 2:17 pm EST | Form 4 |
| Paris PanayiotopoulosPresident and CEO | 0 | — | 0 | Feb 16, 2017 · 2:15 pm EST | Form 4 |
| Hugh M ColeSVP, Chief Business Officer | 0 | — | 0 | Feb 16, 2017 · 2:16 pm EST | Form 4 |
| Sarah J. SchlesingerDirector | 0 | 0 | 0 | Feb 16, 2017 · 2:18 pm EST | Form 4 |
| Manmeet Singh SoniEVP, CFO & Treasurer | 0 | — | 0 | Feb 16, 2017 · 2:14 pm EST | Form 4 |
| Daniel M BollagSr. VP, Reg. Affairs & Quality | 0 | — | 0 | Feb 16, 2017 · 2:15 pm EST | Form 4 |
| Alexander J DennerDirector | 0 | 0 | 0 | Feb 16, 2017 · 2:14 pm EST | Form 4 |
| Anna ProtopapasDirector | 0 | — | 0 | Feb 16, 2017 · 2:15 pm EST | Form 4 |
| Jules HaimovitzDirector | 0 | — | 0 | Feb 16, 2017 · 2:17 pm EST | Form 4 |
| George BickerstaffDirector | 0 | — | 0 | Feb 16, 2017 · 2:17 pm EST | Form 4 |
| Timothy P ClacksonPresident, R&D, CSO | 0 | — | 0 | Feb 16, 2017 · 2:18 pm EST | Form 4 |
| Norbert G RiedelDirector | 0 | — | 0 | Feb 16, 2017 · 2:16 pm EST | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.